A ONE-YEAR PRAGMATIC TRIAL OF NALTREXONE VS DISULFIRAM IN THE TREATMENT OF ALCOHOL DEPENDENCE
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
AIMS: To compare the efficacy of naltrexone and disulfiram in preventing an alcoholic relapse in routine clinical practice in an Indian metropolis. METHODS: Hundred alcohol-dependent men, for whom a family member would accompany the patient to follow-up appointments, were randomly allocated to a year of treatment with either naltrexone or disulfiram. Patients, the accompanying family member and the treating psychiatrist were aware of the nature of treatment given. Alcohol consumption, craving and adverse events were recorded weekly for the first three months, then fortnightly for the rest of the year, by the treating psychiatrist. Serum gamma-glutamyl transferase (GGT) was measured at the start and the end of the study. RESULTS: At the end of the year, 97 patients were still in contact. Relapse, the consumption of >5 drinks (40 g of ethanol) in a 24 h period, occurred at a mean of 119 days with disulfiram and at 63 days with naltrexone (P = 0.020). Mean serum GGT, which had not differed between the two groups initially, was 117 U/l with naltrexone and 85 U/l with disulfiram (P = 0.038) at the end of the study. Eighty-six per cent of the patients remained abstinent throughout the study with disulfiram compared to 44% with naltrexone (P = 0.0009). However, patients allocated to naltrexone had significantly lower craving than those allocated to disulfiram. CONCLUSIONS: Disulfiram is superior to naltrexone in preventing a relapse among alcohol-dependent men with family support. Comparison between these treatments in other settings and in different types of alcoholics is warranted.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the five Indian studies [24], [33], [35], [36], [37], family members were asked to supervise, but there was no real method to verify this supervision.”
From Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis (2014) · cites this paper as [35]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Mendelson, G. (1995) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679509064964 · Cited by 2,858
Anton, R. F., Moak, D. H., & Latham, P. (1995) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01475.x · Cited by 677
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
The Severity of Alcohol Dependence Questionnaire: Its Use, Reliability and Validity
Stockwell, T., Murphy, D., & Hodgson, R. (1983) · British Journal of Addiction · doi:10.1111/j.1360-0443.1983.tb05502.x · Cited by 573
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
Kranzler, H. R., & Van Kirk, J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02356.x · Cited by 390
Benjamin, D., Grant, E. R., & Pohorecky, L. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90309-b · Cited by 237
Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228 · cited 1×
“Naltrexone is an opioid receptor antagonist with a proven history in reducing euphoria, alcohol intake and reducing the risk of relapse in alcoholic patients (Kranzler and Van Kirk, 2001; Streeton and Whelan, 2001).”
BackgroundDoes disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182 · cited 2×
“Deterrent agents such as disulfiram and naltrexone may be of use in the long term ( Fuller and Gordis, 2004 ).”
Background
Research works printed but not linked: 1
- Catafau, A. M., Etcheberrigaray, A., Perez de los Cobos, J., Estorch, M., Guardia, J., Flotas, A., Berna, L., Mari, C., Casas, M. and Carrio, I. (1999) Regional blood flow changes after naltrexone administration in alcoholic patients. Journal of Nuclear Medicine40, 19–24.
Cited by
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087366 · Cited by 347
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Opioid antagonists for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub3 · Cited by 247
Substance use and addiction research in India
Murthy, P., Manjunatha, N., Subodh, B., Chand, P., & Benegal, V. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69232 · Cited by 194
Laaksonen, E., Koski-Jännes, A., Salaspuro, M., Ahtinen, H., & Alho, H. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm136 · Cited by 147
“The De Sousas have compared DIS to NTX (De Sousa and De Sousa, 2004) and to ACA (de Sousa and de Sousa, 2005).”
MethodEvidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
van den Brink, W. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010003 · Cited by 116
Medical Treatment of Alcohol Dependence: A Systematic Review
Miller, P. M., Book, S. W., & Stewart, S. H. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.3.b · Cited by 107
Acute effects of Naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice
Kamdar, N., Miller, S. A., Syed, Y. M., Bhayana, R., Gupta, T., & Rhodes, J. S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0711-5 · Cited by 119
An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh187 · Cited by 107
Martinotti, G., Di Nicola, M., Di Giannantonio, M., & Janiri, L. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108089596 · Cited by 102
Soyka, M., Kranzler, H. R., Hesselbrock, V., Kasper, S., Mutschler, J., Möller, H.-J., & The WFSBP Task Force on Treatment Guidelines for Substance Use Disorders (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1246752 · Cited by 85
Endogenous opiates and behavior: 2004
Bodnar, R. J., & Klein, G. E. (2005) · Peptides · doi:10.1016/j.peptides.2005.06.010 · Cited by 101
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence
Sousa, A. A. D., Sousa, J. D., & Kapoor, H. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.012 · Cited by 96
Pharmacological approaches to reducing craving in patients with alcohol use disorders
Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs · doi:10.1007/s40263-014-0149-3 · Cited by 83
Soyka, M., Kranzler, H. R., Berglund, M., Gorelick, D., Hesselbrock, V., Johnson, B. A., Möller, H.-J., THE WFSBP TASK FORCE ON TREATMENT G, Soyka, M., Kranzler, H. R., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970801896390 · Cited by 80
Martinotti, G., Nicola, M. D., Romanelli, R., Andreoli, S., Pozzi, G., Moroni, N., & Janiri, L. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.833 · Cited by 73
Role of exercise in the treatment of alcohol use disorders
Manthou, E., Georgakouli, K., Fatouros, I. G., Gianoulakis, C., Theodorakis, Y., & Jamurtas, A. Z. (2016) · Biomedical Reports · doi:10.3892/br.2016.626 · Cited by 74
“The detoxification procedure involves psychological and/or pharmacological support and an extensive follow-up period (6,7).”
Diehl, A., Ulmer, L., Mutschler, J., Herre, H., Krumm, B., Croissant, B., Mann, K., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq017 · Cited by 49
Staton, C. A., Vissoci, J. R. N., El-Gabri, D., Adewumi, K., Concepcion, T., Elliott, S. A., Evans, D. R., Galson, S. W., Pate, C. T., Reynolds, L. M., et al. (2022) · PLOS Medicine · doi:10.1371/journal.pmed.1003961 · Cited by 41
“De Sousa and colleagues (2004) [46] India Biomedical treatments Private hospital adult psychiatric patients 100 High Abstinence days Days until relapse Drinks per drinking day Craving”
BackgroundYoshimura, A., Kimura, M., Nakayama, H., Matsui, T., Okudaira, F., Akazawa, S., Ohkawara, M., Cho, T., Kono, Y., Hashimoto, K., et al. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12278 · Cited by 48
Ripley, T. L., & Stephens, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01406.x · Cited by 50
Schick, M. R., Spillane, N. S., & Hostetler, K. L. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14440 · Cited by 35
Aguiar, P. M. V., Neto, D., Lambaz, R., Chick, J., & Ferrinho, P. D. L. G. M. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags097 · Cited by 40
The Pharmacotherapy of Alcohol Dependence: A State of the Art Review
Sousa, A. D. (2010) · Mens Sana monographs · doi:10.4103/0973-1229.58820 · Cited by 32
An Approach to the Patient with Substance Use and Abuse
Maldonado, J. R. (2010) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.08.010 · Cited by 35
Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark, T. L., Montejano, L. B., Kranzler, H. R., Chalk, M., & Gastfriend, D. R. (2010) · PubMed · Cited by 32
Relationship between Craving and Early Relapse in Alcohol Dependence: A Short-Term Follow-up Study
Kharb, R., Shekhawat, L. S., Beniwal, R. P., Triptish Bhatia, A., & Deshpande, S. N. (2018) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_558_17 · Cited by 31
An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence
De Sousa, A., & De Sousa, A. (2008) · Journal of Substance Use · doi:10.1080/14659890802305861 · Cited by 29
Badawy, A. A.-B., Bano, S., & Steptoe, A. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agr134 · Cited by 29
Disulfiram in severe alcoholism–an open controlled study
Ulrichsen, J., Nielsen, M. K., & Ulrichsen, M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039481003686180 · Cited by 26
Thirthalli, J., & Chand, P. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832a1dc0 · Cited by 26
Neto, D., Lambaz, R., & Tavares, J. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm062 · Cited by 24
Antonelli, M., Sestito, L., Tarli, C., & Addolorato, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.016 · Cited by 28
Bloor, R. N., Španěl, P., & Smith, D. C. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00015.x · Cited by 22
Disulfiram, an Option for the Treatment of Pathological Gambling?
Mutschler, J., Fauth‐Bühler, M., Grosshans, M., Diehl, A., Mann, K. F., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp093 · Cited by 24
Supervised Disulfiram in the Treatment of Alcohol Use Disorder: A Commentary
Krampe, H., Spies, C., & Ehrenreich, H. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01519.x · Cited by 20
Mutschler, J., Grosshans, M., Koopmann, A., Hermann, D., Diehl, A., Mann, K. F., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq001 · Cited by 18
Effect of the threat of a disulfiram–ethanol reaction on cue reactivity in alcoholics
Skinner, M. D., Coudert, M., Berlin, I., Passeri, E., Michel, L., & Aubin, H.-J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.011 · Cited by 17
Mutschler, J., Dirican, G., Funke, S., Obermann, C., Grosshans, M., Mann, K. F., Kiefer, F., & Diehl, A. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182216fd5 · Cited by 17
Neto, D., Lambaz, R., Aguiar, P. M. V., & Chick, J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn075 · Cited by 16
Impact of brief relapse prevention intervention in patients with alcohol dependence in Zambia
Sheikh, W. A., Paul, R., Banda, H., Agath, K., & Luty, J. (2017) · Journal of Substance Use · doi:10.3109/14659891.2015.1090494 · Cited by 14
Sarkar, S., Tom, A., Das, S., Bharadwaj, B., & Ghosh, A. (2022) · Journal of Mental Health and Human Behaviour · doi:10.4103/jmhhb.jmhhb_191_20 · Cited by 15
Status of disulfiram in present day alcoholic deaddiction therapy
Saldanha, E., & Palatty, P. L. (2011) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.75557 · Cited by 18
Disulfiram in the management of alcohol dependence: A comprehensive clinical review
Kalra, G., Sousa, A. D., & Shrivastava, A. (2014) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2014.41007 · Cited by 40
A breath test to assess compliance with disulfiram
Fletcher, K., Stone, E., Mohamad, M. W., Faulder, C. G., Faulder, R. M., Jones, K., Morgan, D., Wegerdt, J., Kelly, M., & Chick, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01602.x · Cited by 12
Tarli, C., Mirijello, A., & Addolorato, G. (2022) · Seminars in Liver Disease · doi:10.1055/a-1798-2872 · Cited by 12
Greene, M. C., Kane, J., Alto, M., Giusto, A., Lovero, K., Stockton, M., McClendon, J., Nicholson, T., Wainberg, M. L., Johnson, R. M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013350.pub2 · Cited by 11
Update on the Pharmacological Treatment of Pathological Gambling
Bullock, S. A., & Potenza, M. N. (2014) · Current Psychopharmacologye · doi:10.2174/22115560113029990008 · Cited by 12
Bogenschutz, M. P., Bhatt, S. R., Bohan, J., Foster, B., Romo, P., Wilcox, C. E., & Tonigan, J. S. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1168430 · Cited by 11
Bharadwaj, B., Selvakumar, N., & Kuppili, P. P. (2018) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_79_17 · Cited by 10
Elmosalamy, A., Sirohi, A., Moustafa, A., Masoud, O., Hassett, L. C., Kolla, B. P., & Singh, B. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112789 · Cited by 11
Manjunatha, N., Vidyendaran, R., Rao, M., Kulkarni, G. B., Muralidharan, K., John, J. P., Amar, B. R., & Jain, S. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.190397 · Cited by 7
“Disulfiram is a deterrent agent, prescribed to motivated patients, with their informed consent for the relapse prevention of alcohol dependence (AD).”
BackgroundPharmakologische Rückfallprophylaxe bei Alkoholabhängigkeit
Kiefer, F., & Löber, S. (2007) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-2007-986228 · Cited by 7
A comparative study using Disulfiram and Naltrexone in alcohol-dependent adolescents
Sousa, A. D. (2013) · Journal of Substance Use · doi:10.3109/14659891.2013.813084 · Cited by 8
Disulfiram in Context: Structure and Safety
Martin, B., & Beresford, T. P. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280312.58495.35 · Cited by 7
Effet antabuse sévère aggravé par la dopamine
Amireche, N., Petit, J.-S., Bankole, E., Fournet-Fayard, A., Appriou, M., & Leon, A. (2011) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2010.11.022 · Cited by 6
Basu, D., & Joseph, J. (2019) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1307 · Cited by 6
Morice, C., Yammine, L., Yoon, J. S., Lane, S. D., Schmitz, J. M., Kosten, T. R., Garza, R. D. L., & Verrico, C. D. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110506 · Cited by 8
Ávila, P., Marcos, M., Ávila, J. J. G., & Laso, F. J. (2008) · Revista Clínica Española · doi:10.1157/13128674 · Cited by 5
Basu, D., Ghosh, A., Patra, B., & Subodh, B. N. (2015) · Springer eBooks · doi:10.1007/978-81-322-1674-2_19 · Cited by 5
Treatment outcome and its predictors among A sian problem drinkers
Manning, V., Gomez, B. M., Koh, P. K., Ng, A. Y., Guo, S. L., Kandasami, G., & Wong, K. E. (2012) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2012.00518.x · Cited by 7
Disulfiram (Antabus ®) in der Suchtbehandlung
Olbrich, R., & Olbrich, R. (2007) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/2007.02.02 · Cited by 5
Kumar, R., Quraishi, R., Sarkar, S., Rao, R., & Ambekar, A. (2024) · addiction and health · doi:10.34172/ahj.1494 · Cited by 4
Why is disulfiram not on the PBS?
Lipworth, W. L., WODAK, A. D., Haber, P., & Day, R. O. (2011) · The Medical Journal of Australia · doi:10.5694/mja11.10708 · Cited by 4
Nayak, V., Chogtu, B., Devaramane, V., & Bhandary, P. (2011) · Case Study and Case Report · Cited by 3
Zyl, P. M. V. (2016) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v8i1.1053 · Cited by 3
Cho, T., Negoro, H., Saka, Y., Morikawa, M., & Kishimoto, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s111230 · Cited by 5
Varshney, M., Kaur, A., Sarin, S. K., Shasthry, S. M., & Arora, V. K. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102447 · Cited by 4
Brewer, C. L., & Streel, E. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-197-0_26 · Cited by 4
Drug and alcohol addiction: new pharmacotherapies
Luty, J. S. (2015) · BJPsych Advances · doi:10.1192/apt.bp.114.013367 · Cited by 4
The evidence for drug treatment of alcohol dependence in liver transplant patients
Beresford, T. P., & Martin, B. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32803fb77d · Cited by 3
Disulfiram: The Survivor Medication
Alharbi, F., & el‐Guebaly, N. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318246f4af · Cited by 2
Basu, D., Ghosh, A., & Sarkar, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00094-7 · Cited by 3
Disulfiram in the Management of Alcohol Dependence
Sousa, A. D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9876-7_3 · Cited by 4
Brewer, C. L. (2010) · Intervention · doi:10.1097/wtf.0b013e328341363b · Cited by 1
Aguiar, P. M. V., Neto, D., Lambaz, R., Chick, J., & Ferrinho, P. D. L. G. M. (2016) · Cited by 1
Treatment of alcohol dependence
Chick, J. (2012) · doi:10.1093/med/9780199696758.003.0059 · Cited by 1
Lesch, O., Walter, H., Wetschka, C., Hesselbrock, M. N., HESSELBROCK, V. M., & Pombo›, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-41941-7_9 · Cited by 2
Reply to Comments by Mr Martin and Dr Beresford
Suh, J. J., Gallis, T. L., Kampman, K. M., & Pettinati, H. M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280313.96613.72 · Cited by 1
Pharmacological Long-Term Treatment of Alcohol Use Disorders
Mann, K. F., & Kiefer, F. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_12 · Cited by 1
CASE REPORT Disulfiram, an Option for the Treatment of Pathological Gambling?
Mutschler, J., Fauth‐Bühler, M., Grosshans, M., Diehl, A., Mann, K. F., & Kiefer, F. (2009)
Aslan, A. A., Yalçın, Ö., Arıkan, Z., Kuruoğlu, A., Çoşar, B., & Konuk, N. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120903122839
Martínez, R. L., Francés, M. D. C., Gallús, E. M., Cervera, C. A., & Caballero, L. A. (2008) · Adicciones · doi:10.20882/adicciones.271
Berglund, M. (2007) · Lund University Publications (Lund University)
13 Common Errors in Psychopharmacology
Ameen, S. (2015) · Kerala Journal of Psychiatry · doi:10.30834/kjp.28.2.2015.54 · Cited by 2
Pharmacological treatment options for alcohol use disorder
Evren, C., & Bozkurt, M. (2015) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20152804001
Specialist treatment of drinking problems
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.014
Alcohol problems in the general hospital
Chick, J. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543975.009
Commentary: Disulfiram and the Zenalyser®: Teaching an Old Dog New Tricks
Fletcher, K. (2017) · JOURNAL OF MENTAL HEALTH AND CLINICAL PSYCHOLOGY · doi:10.29245/2578-2959/2018/1.1109
Böning, J., Kienast, T., Heinz, A., Lesch, O., Soyka, M., Wiesbeck, G. A., Böning, J., Wodarz, N., Platz, W. E., Scherbaum, N., et al. (2007) · Springer eBooks · doi:10.1007/3-211-37774-3_4 · Cited by 1
Disulfiram in Comparison and Combination with Other Agents in the Management of Alcohol Dependence
Sousa, A. D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9876-7_5
Cho, T. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_342-1
Therapeutische Strategien bei Alkohol- und Tabakabhängigkeit
Lesch, O., Walter, H., Pombo›, S., HESSELBROCK, V. M., & Hesselbrock, M. N. (2020) · Springer eBooks · doi:10.1007/978-3-662-60284-3_9
Pharmacological Treatment of Alcohol Use Disorder
Trick, L., & Foll, B. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_10 · Cited by 1
Treatment: Context and content
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.009
Pharmacotherapy of alcohol misuse, dependence and withdrawal
Kenna, G. A., Agath, K., & Swift, R. M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.016
Current awareness in human psychopharmacology
(2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.635
Metadata
- Authors
- DE SOUSA, A., & DE SOUSA, A.
- Venue
- Alcohol and Alcoholism
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 6
- Pages
- 528-531
- ISSN
- 0735-0414 (ISSN-L)
- 1464-3502
- OpenAlex
- W2123760900
- Cited by
- 108
- References
- 16
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 6 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 10 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Alcohol and Alcoholism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- alcoholism, naltrexone, disulfiram, alcohol relapse prevention, alcohol craving, alcohol abstinence, family support, gamma-glutamyl transferase, drug therapy comparison
- MeSH terms
- Adult, Alcohol Deterrents, Alcoholism, Analysis of Variance, Disulfiram, gamma-Glutamyltransferase, Humans, India, Male, Middle Aged, Naltrexone, Social Support, Chi-Square Distribution, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.